作者: Jr. George L. Wright
DOI:
关键词:
摘要: The invention provides for the detection and quantification of PSMA, PSMA', other prostatic markers in serum samples as well types use differentiating prostate cancer, benign hyperplasia, negative diagnoses. diagnostic nucleic acids, such mRNAs, which encode cell lysates sample sources is also provided. In addition to multiplexed detection/quantification these protein- acid-based markers, includes biochips, kits integrated systems.